BHC
SRPT icon

Bull Harbor Capital’s Sarepta Therapeutics SRPT Stock Holding History

Bull Harbor Capital’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$243K Sell
13,517
-4,781
-26% -$90.4K 0.05% 473
2026
Q1 		$398K Buy
+18,298
New +$354K 0.11% 278

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Bull Harbor Capital's SRPT Position: Q2 2026 in Review

Bull Harbor Capital reduced its Sarepta Therapeutics (SRPT) stake by 26% in Q2 2026, selling an estimated $90.4K and leaving 13,517 shares worth $243K. The position accounts for 0.05% of the portfolio, ranked #473.

Bull Harbor Capital first reported a position in SRPT in Q1 2026 and has held it in 2 quarters since. The position peaked at $398K in Q1 2026. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • Bull Harbor Capital held 13,517 shares of Sarepta Therapeutics worth $243K as of Q2 2026.
  • Bull Harbor Capital sold 4,781 Sarepta Therapeutics shares in Q2 2026, an estimated $90.4K.
  • Sarepta Therapeutics made up 0.05% of Bull Harbor Capital's portfolio in Q2 2026, its #473 holding.
  • Bull Harbor Capital first reported a position in Sarepta Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • Bull Harbor Capital's Sarepta Therapeutics position peaked at $398K in Q1 2026.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on Bull Harbor Capital's 13F filing for Q2 2026, filed 10 Aug 2026.